PTPRO and hepatocellular carcinoma: We verified this potential regulation mechanism by investigating the serum IL-6 levels in patients with HCC by ELISA (online supplementary figure s12) and by performing a linear correlation study between the serum IL-6 levels and expression of miR-25–3 p or PTPRO in HCC monocytes.